Other
EMA
EMA is an intervention with 4 clinical trials. Currently 3 active trials ongoing.
Total Trials
4
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Active Trials
3(75%)
Phase Distribution
Ph not_applicable
3
75%
Ph early_phase_1
1
25%
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Early Phase 1First-in-human
1(25.0%)
N/ANon-phased studies
3(75.0%)
Highest Phase Reached
Early Phase 1Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
3
trials recruiting
Total Trials
4
all time
Status Distribution
Active(3)
Other(1)
Detailed Status
Recruiting3
unknown1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
3
Success Rate
N/A
Most Advanced
Early Phase 1
Trials by Phase
Early Phase 11 (25.0%)
N/A3 (75.0%)
Trials by Status
recruiting375%
unknown125%
Recent Activity
3 active trials
Showing 4 of 4
recruitingnot_applicable
EMI Therapy for Depression in Hong Kong
NCT06430476
recruitingnot_applicable
Neurobehavioral Mechanisms of Social Isolation and Loneliness in Serious Mental Illness
NCT04940663
recruitingnot_applicable
SmartCriseS - Smartphone Survey of Suicidal Risk
NCT03720730
unknownearly_phase_1
An Integrated Closed-loop Feedback System for Pediatric Cardiometabolic Disease
NCT02659163
Clinical Trials (4)
Showing 4 of 4 trials
NCT06430476Not Applicable
EMI Therapy for Depression in Hong Kong
NCT04940663Not Applicable
Neurobehavioral Mechanisms of Social Isolation and Loneliness in Serious Mental Illness
NCT03720730Not Applicable
SmartCriseS - Smartphone Survey of Suicidal Risk
NCT02659163Early Phase 1
An Integrated Closed-loop Feedback System for Pediatric Cardiometabolic Disease
All 4 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 4